In vivo analysis of Nef's role in HIV-1 replication, systemic T cell activation and CD4+ T cell loss

被引:21
|
作者
Watkins, Richard L. [1 ]
Foster, John L. [1 ]
Garcia, J. Victor [1 ]
机构
[1] Univ N Carolina, Div Infect Dis, UNC Ctr AIDS Res, Genet Med, Chapel Hill, NC 27599 USA
来源
RETROVIROLOGY | 2015年 / 12卷
基金
美国国家卫生研究院;
关键词
HIV-1; Nef; Replication; Pathogenesis; IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN LYMPHOID-TISSUE; HUMANIZED BLT MICE; EX-VIVO; DISEASE PROGRESSION; IMMUNE EVASION; HOST-CELL; INFECTION; TRANSMISSION; DEPLETION;
D O I
10.1186/s12977-015-0187-z
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Nef is a multifunctional HIV-1 protein critical for progression to AIDS. Humans infected with nef(-) HIV-1 have greatly delayed or no disease consequences. We have contrasted nef(-) and nef(+) infection of BLT humanized mice to better characterize Nef's pathogenic effects. Results: Mice were inoculated with CCR5-tropic HIV-1(JRCSF) (JRCSF) or JRCSF with an irreversibly inactivated nef (JRCSFNefdd). In peripheral blood (PB), JRCSF exhibited high levels of viral RNA (peak viral loads of 4.71 x 10(6) +/- 1.23 x 10(6) copies/ml) and a progressive, 75% loss of CD4(+) T cells over 17 weeks. Similar losses were observed in CD4(+) T cells from bone marrow, spleen, lymph node, lung and liver but thymocytes were not significantly decreased. JRCSFNefdd also had high peak viral loads (2.31 x 10(6) +/- 1.67 x 10(6)) but induced no loss of PB CD4(+) T cells. In organs, JRCSFNefdd produced small, but significant, reductions in CD4(+) T cell levels and did not affect the level of thymocytes. Uninfected mice have low levels of HLA-DR(+)CD38(+)CD8(+) T cells in blood (1-2%). Six weeks post inoculation, JRCSF infection resulted in significantly elevated levels of activated CD8(+) T cells (6.37 +/- 1.07%). T cell activation coincided with PB CD4(+) T cell loss which suggests a common Nef-dependent mechanism. At 12 weeks, in JRCSF infected animals PB T cell activation sharply increased to 19.7 +/- 2.9% then subsided to 5.4 +/- 1.4% at 14 weeks. HLA-DR(+)CD38(+)CD8(+) T cell levels in JRCSFNefdd infected mice did not rise above 1-2% despite sustained high levels of viremia. Interestingly, we also noted that in mice engrafted with human tissue expressing a putative protective HLA-B allele (B42:01), JRCSFNefdd exhibited a substantial (200-fold) reduced viral load compared to JRCSF. Conclusions: Nef expression was necessary for both systemic T cell activation and substantial CD4(+) T cell loss from blood and tissues. JRCSFNefdd infection did not activate CD8(+) T cells or reduce the level of CD4(+) T cells in blood but did result in a small Nef-independent decrease in CD4(+) T cells in organs. These observations strongly support the conclusion that viral pathogenicity is mostly driven by Nef. We also observed for the first time substantial host-specific suppression of HIV-1 replication in a small animal infection model.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] CD4+ and CD8+ T Cell Activation Are Associated with HIV DNA in Resting CD4+ T Cells
    Cockerham, Leslie R.
    Siliciano, Janet D.
    Sinclair, Elizabeth
    O'Doherty, Una
    Palmer, Sarah
    Yukl, Steven A.
    Strain, Matt C.
    Chomont, Nicolas
    Hecht, Frederick M.
    Siliciano, Robert F.
    Richman, Douglas D.
    Deeks, Steven G.
    PLOS ONE, 2014, 9 (10):
  • [32] Expression of HIV-1 pathogenesis factor NEF in CD4 T cells impairs antigen-specific B-cell function
    Kaw, Sheetal
    Ananth, Swetha
    Tsopoulidis, Nikolaos
    Morath, Katharina
    Coban, Bahar M.
    Hohenberger, Ralph
    Bulut, Olcay C.
    Klein, Florian
    Stolp, Bettina
    Fackler, Oliver T.
    EMBO JOURNAL, 2020,
  • [33] Rab11-FIP1C Is Dispensable for HIV-1 Replication in Primary CD4+ T Cells, but Its Role Is Cell Type Dependent in Immortalized Human T-Cell Lines
    de Cespedes, Melissa V. Fernandez V.
    Hoffman, Huxley K.
    Carter, Hannah
    Simons, Lacy M.
    Naing, Lwar
    Ablan, Sherimay D.
    Scheiblin, David A.
    Hultquist, Judd F.
    van Engelenburg, Schuyler B.
    Freed, Eric O.
    JOURNAL OF VIROLOGY, 2022, 96 (23)
  • [34] HIV-1 persistence in CD4+ T cells with stem cell like properties
    Buzon, Maria J.
    Sun, Hong
    Li, Chun
    Shaw, Amy
    Seiss, Katherine
    Ouyang, Zhengyu
    Martin-Gayo, Enrique
    Leng, Jin
    Henrich, Timothy J.
    Li, Jonathan Z.
    Pereyra, Florencia
    Zurakowski, Ryan
    Walker, Bruce D.
    Rosenberg, Eric S.
    Yu, Xu G.
    Lichterfeld, Mathias
    NATURE MEDICINE, 2014, 20 (02) : 139 - 142
  • [35] In Vivo Blockade of the PD-1 Receptor Suppresses HIV-1 Viral Loads and Improves CD4+ T Cell Levels in Humanized Mice
    Palmer, Brent E.
    Neff, C. Preston
    LeCureux, Jonathan
    Ehler, Angelica
    DSouza, Michelle
    Remling-Mulder, Leila
    Korman, Alan J.
    Fontenot, Andrew P.
    Akkina, Ramesh
    JOURNAL OF IMMUNOLOGY, 2013, 190 (01) : 211 - 219
  • [36] HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients
    Joshi, Anjali
    Sedano, Melina
    Beauchamp, Bethany
    Punke, Erin B.
    Mulla, Zuber D.
    Meza, Armando
    Alozie, Ogechika K.
    Mukherjee, Debabrata
    Garg, Himanshu
    JOURNAL OF IMMUNOLOGY, 2016, 196 (04) : 1768 - 1779
  • [37] Asymmetric HIV-1 co-receptor use and replication in CD4+ T lymphocytes
    Mariani, Samanta A.
    Vicenzi, Elisa
    Poli, Guido
    JOURNAL OF TRANSLATIONAL MEDICINE, 2011, 9
  • [38] Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers
    Saez-Cirion, Asier
    Hamimi, Chiraz
    Bergamaschi, Anna
    David, Annie
    Versmisse, Pierre
    Melard, Adeline
    Boufassa, Faroudy
    Barre-Sinoussi, Francoise
    Lambotte, Olivier
    Rouzioux, Christine
    Pancino, Gianfranco
    BLOOD, 2011, 118 (04) : 955 - 964
  • [39] Strong Ability of Nef-Specific CD4+ Cytotoxic T Cells To Suppress Human Immunodeficiency Virus Type 1 (HIV-1) Replication in HIV-1-Infected CD4+ T Cells and Macrophages
    Zheng, Nan
    Fujiwara, Mamoru
    Ueno, Takamasa
    Oka, Shinichi
    Takiguchi, Masafumi
    JOURNAL OF VIROLOGY, 2009, 83 (15) : 7668 - 7677
  • [40] HIV-1 REPLICATION IS CONTROLLED AT THE LEVEL OF T-CELL ACTIVATION AND PROVIRAL INTEGRATION
    STEVENSON, M
    STANWICK, TL
    DEMPSEY, MP
    LAMONICA, CA
    EMBO JOURNAL, 1990, 9 (05) : 1551 - 1560